These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6482659)

  • 21. Effects of adrenomedullin 2 on regional hemodynamics in conscious rats.
    Fujisawa Y; Nagai Y; Miyatake A; Miura K; Nishiyama A; Kimura S; Abe Y
    Eur J Pharmacol; 2007 Mar; 558(1-3):128-32. PubMed ID: 17204266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of desensitization of vasodilatation induced by platelet-activating factor in hypertensive rats.
    Kamata K; Numazawa T; Kasuya Y
    Eur J Pharmacol; 1996 Apr; 301(1-3):121-8. PubMed ID: 8773455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radioisotope study of regional hemodynamic effects of reserpine in rats with normal blood pressure and in hypertensive rats].
    Bralet AM; Rochette L; Bralet J
    Therapie; 1974; 29(6):811-8. PubMed ID: 4462230
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
    Rizzo A; Taylor AE; Townsley MI; Logsdon P; Khimenko PL; Fletcher JR
    Am J Physiol; 1995 May; 268(5 Pt 2):H1954-8. PubMed ID: 7771545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary vascular response to platelet-activating factor in conscious sheep.
    Toyofuku T; Kobayashi T; Koyama S; Kusama S
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H434-40. PubMed ID: 3414811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs.
    Tanaka S; Kasuya Y; Masuda Y; Shigenobu K
    J Pharmacobiodyn; 1983 Nov; 6(11):866-73. PubMed ID: 6668545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of pentoxifylline on cochlear blood flow in normotensive and spontaneously hypertensive rats.
    Quirk WS; Dengerink HA; Bademian MJ; Hall KW; Wright JW
    Hear Res; 1988 Nov; 36(2-3):175-80. PubMed ID: 3209490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of two ergot derivatives in the conscious spontaneously hypertensive rat.
    Susić D; Djordjević N; Kentera D
    Pharmacology; 1984; 29(4):215-23. PubMed ID: 6494233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in regional blood flow in rats following sensitization to the nematode Nippostrongylus brasiliensis: effects of PAF antagonists.
    Mathison R; Rimmer C; Davison JS; Wallace JL; Befus AD
    Br J Pharmacol; 1990 Sep; 101(1):93-6. PubMed ID: 2282473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F; Calabrese R; Stati T; del Basso P
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketanserin: systemic and regional hemodynamics in spontaneously hypertensive rats. Role of alpha 1-adrenoceptor blockade.
    Richer C; Scalbert E; Doussau MP; Duhaze P; Giudicelli JF
    Eur J Pharmacol; 1987 Jul; 139(1):31-42. PubMed ID: 2888664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
    Watkins RW; Sybertz EJ; Cook J; Pula K; Cedeno K; Tedesco RP; McLeod R
    Arch Int Pharmacodyn Ther; 1989; 302():158-73. PubMed ID: 2576892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of acute and chronic cilazapril treatment in spontaneously hypertensive rats.
    Fischli W; Hefti F; Clozel JP
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):151S-158S. PubMed ID: 2527529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Am J Hypertens; 2004 Apr; 17(4):328-33. PubMed ID: 15062886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
    Kost CK; Herzer WA; Li P; Jackson EK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of systemic platelet-activating factor (PAF) on the rabbit spinal cord microcirculation.
    Lindsberg PJ; Jacobs TP; Paakkari IA; Hallenbeck JM; Feuerstein G
    J Lipid Mediat; 1990; 2(1):41-58. PubMed ID: 2133267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat.
    Bellan JA; Minkes RK; Hood JS; McMahon TJ; Higuera TR; Nossaman BD; McNamara DB; Kadowitz PJ
    Am J Physiol; 1992 Jul; 263(1 Pt 2):H234-43. PubMed ID: 1379004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.